23andMe Reports Improved Financial Metrics Amid Revenue Decline
Andme Holding Co ( (ME) ) has released its Q2 earnings. Here is a breakdown of the information 23Andme Holding Co presented to its investors.
Le Lézard32m
Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
Highly competitive, clinical-stage portfolio accelerating Phase 2 trials of ultra-long acting, fully-biased injectable GLP-1 RA underway Metsera recently reported significant and durable weight loss ...